Author, year | Study details | Study population | Intervention | Type of milk | Placebo |
---|---|---|---|---|---|
- Strain | |||||
- Dose (D) | |||||
- Start of treatment (S) | |||||
- End of treatment (E) | |||||
Al-Hosni, 2012 [33] | P | Preterm infants with BW 501–1000 g, appropriate for gestational age, and ≤ 14 days of age at time of feeding initiation | Lactobacillus rhamnosus GG LGG | Non specified | Extra milk |
DB | Bifidobacterium infantis | ||||
R | D: 0.5 × 109 CFU each probiotic, OD | ||||
C | S: first enteral feeding | ||||
Multic. | E: discharge or until 34 w postmenstrual age | ||||
Bin-Nun, 2005 [40] | P | Preterm infants with BW < 1500 g, who began enteral feeding on a weekday | Bifidobacterium infantis | OMM, PFM | HM or FM |
B | Streptococcus thermophilus | ||||
R | Bifidobacterium bifidus | ||||
C | D: 0.35 × 109 CFU each probiotic, OD | ||||
S: start of enteral feeding | |||||
E: 36 w postconceptual age | |||||
Braga, 2011 [35] | P | Inborn infants with BW 750–1499 g | Lactobacillus casei | HM | Extra HM |
DB | Bifidobacterium breve | ||||
R | D: 3.5 × 107 CFU to 3.5 × 109 CFU OD | ||||
C | S: day 2 | ||||
E: day 30, NEC diagnosis, discharge, death, whichever occurred first | |||||
Costalos, 2003 [49] | P | GA 28–32 w | Saccharomyces boulardii | PFM | MDX |
R | No major GI problem | D: 1 × 109 CFU BD | |||
C | Not receiving antibiotics | S: non-specified | |||
Not receiving breast milk | Median duration of probiotic supplementation: 30Â days | ||||
Dani, 2002 [42] | P | Infants with GA < 33 w or BW < 1500 g | Lactobacillus rhamnosus GG | OMM, DM or FM | MDX |
DB | D: 6 × 109 CFU OD | ||||
R | S: first feed | ||||
C | E: discharge | ||||
Multic. | |||||
Demirel, 2013 [28] | P | Preterm infants with GA ≤ 32 w and BW ≤ 1500 g, who survived to feed enterally | Saccharomyces boulardii | HM, FM | None |
B | D: 5 × 109 CFU OD | ||||
R | S: first feed | ||||
C | E: discharge | ||||
Dilli, 2015 [44] | P | Preterm infants with GA <32Â weeks and BW <1500Â g, born at or transferred to the NICU within the first week of life and fed enterally before inclusion | Bifidobacterium | HM, FM | MDX powder |
DB | Lactis | ||||
R | D: 5 × 109 CFU | ||||
C | S: beyond d7 after birth | ||||
Multic. | E: death or discharge (max 8Â weeks) | ||||
Fernández-Carrocera, 2013 [32] | P | Preterm infants with BW < 1500 g | Lactobacillus acidophilus 1 CFU/g | OMM, PFM | None |
DB | Infants with NEC IA and IB were excluded | Lactobacillus rhamnosus 4.4 × 108 CFU/g | |||
R | Lactobacillus casei 1 × 109 CFU/g | ||||
C | Lactobacillus plantarum 1.76 × 108 CFU/g | ||||
Bifidobacterium infantis 2.76 × 107 CFU/g | |||||
Streptococcus thermophilus 6.6 × 105 CFU/g | |||||
Total D: 1Â g powder OD | |||||
S: start of enteral feeding | |||||
E: non-specified | |||||
Jacobs, 2013 [26] | P | Preterm infants with GA <32 w and BW < 1500 g | Bifidobacterium infantis BB-02 300 CFU × 106 | HM, FM | MDX powder |
DB | Streptococcus thermophilus Th-4 350 CFU × 106 | ||||
R | Bifidobacterium lactis BB-12 350 CFU × 106 | ||||
C | Total D: 1 × 109 CFU × 1.5 g maltodextrin powder OD | ||||
Multic. | S: enteral feed ≥ 1 ml every 4 h | ||||
E: discharge or term corrected age | |||||
Kitajima, 1997 [52] | P | Preterm infants with BW < 1500 g | Bifidobacterium breve YIT4010 | OMM, FM after full enteral feeding had been reached | Distilled water |
R | D: 0.5 × 109 CFU OD | ||||
C | S: within 24Â h of life | ||||
Duration of probiotic supplementation: 28Â days | |||||
Lin, 2005 | P | Infants with BW < 1500 g, who started to feed enterally and survived beyond day 7 | Lactobacillus acidophilus | OMM, DM | None |
M | Bifidobacterium infantis | ||||
R | D: ≥ 106 CFU each probiotic (=125 mg/kg), BD | ||||
C | S: start of enteral feeding | ||||
E: discharge | |||||
Lin, 2008 | P | Preterm infants with GA < 34 w and BW ≤ 1500 g, who survived to feed enterally | Lactobacillus acidophilus NCDO 1746 | HM, FM | None |
B | Bifidobacterium bifidum NCDO 1453 | ||||
R | D: 1 × 109 CFU each probiotic (=125 mg/kg) BD | ||||
C | S: day 2 of age | ||||
Multic. | Duration: 6Â weeks | ||||
Manzoni, 2006 [37] | P | Infants with BW < 1500 g, ≥ 3 days of life, who started enteral feeding with HM | Lactobacillus rhamnosus LGG | OMM, DM | None |
DB | D: 6 × 109 CFU/day | ||||
R | S: day 3 of life | ||||
C | E: end of the 6th week or discharge | ||||
Mihatsch, 2010 [43] | P | Preterm infants with GA < 30 w and BW ≤ 1500 g | Bifidobacterium lactis BB12 | HM, PFM | Indistinguishable powder |
R | D: 2 × 109 CFU/kg 6 times a day | ||||
C | S: start of enteral feeding | ||||
E: non-specified | |||||
Mohan, 2006 [53] | P | Preterm infants (GA < 37 w) | Bifidobacterium lactis BB12 | FM | Not stated |
DB | D: 1.6 × 109 CFU on day 1 to 3, and 4.8 × 109 CFU from day 4 onwards | ||||
R | S: first day of life | ||||
C | Duration: 21Â days | ||||
Oncel, 2013 [25] | P | Preterm infants with GA ≤ 32 w and BW ≤ 1500 g, who survived to feed enterally | Lactobacillus reuteri DSM 17938 | HM, FM | Oil base |
DB | D: 1 × 108 CFU OD | ||||
R | S: first feed | ||||
C | E: death or discharge | ||||
Patole, 2014 [45] | P | Preterm infants with GA < 33 w and BW < 1500 g | Bifidobacterium breve M16-V | HM, FM | Dextrin |
DB | D: 3 × 109 CFU OD (1.5 × 109 CFU OD for newborns ≤ 27 w until they reached 50 ml/kg/day enteral feeds) | ||||
R | S: start of enteral feed | ||||
C | E: corrected age of 37 w | ||||
Rojas, 2012 [30] | P | Preterm infants with BW ≤ 2000 g, hemodynamically stable, ≤ 48 h of age (regardless start of enteral feeding) | Lactobacillus reuteri DSM 17938 | HM, FM | Oil base |
DB | D: 1 × 108 CFU OD | ||||
R | S: age ≤ 48 h | ||||
C | E: death or discharge | ||||
Multic. | |||||
Rougé, 2009 [50] | P | Preterm infants with GA < 32 w and BW < 1500 g, ≤ 2 w of age, without any disease other than those linked to prematurity, who started enteral feeding before inclusion | Bifidobacterium longum BB536 | OMM, DM or PFM | MDX |
DB | Lactobacillus rhamnosus GG BB536-LGG | ||||
R | Total D: 1 × 108 CFU/day | ||||
C | S: start of enteral feeding | ||||
Bic. | E: discharge | ||||
Roy, 2014 [58] | P | Preterm infants (GA < 37w) and BW < 2500 g, with stable enteral feeding within 72 h of birth | Lactobacillus acidophilus 1.25 × 109 CFU × 1 g | HM | Sterile water |
DB | B. longum 0.125 × 109 CFU × 1 g | ||||
R | B. bifidum 0.125 × 109 CFU × 1 g | ||||
C | B. lactis 1 × 109 CFU × 1 g | ||||
D: half a 1Â g sachet | |||||
S: from 72Â h of life | |||||
E: after 6 w or at discharge | |||||
Saengtawesin, 2014 [48] | P | Preterm infants with GA ≤ 34 w and BW ≤ 1500 g | Lactobacillus acidophilus 1 × 109 CFU | HM, PFM | None |
R | Bifidobacterium | ||||
C | bifidum 1 × 109 CFU | ||||
D: 125Â mg/kg BD | |||||
S: start of feeding | |||||
E: 6 w of age or discharge. | |||||
Samanta, 2009 | P | Preterm infants with GA < 32 w and BW < 1500 g, who started enteral feeding and survived beyond 48 h of age | Bifidobacterium infantis | HM | None |
DB | Bifidobacterium bifidum | ||||
R | Bifidobacterium longum | ||||
C | Lactobacillus acidophilus | ||||
D: 2.5 × 109 CFU each probiotic, BD | |||||
S: start of enteral feeding | |||||
E: discharge | |||||
Sari, 2011 [34] | P | Preterm infants with GA < 32 w or BW < 1500 g, who survived to feed enterally | Lactobacillus sporogenes | HM, FM | None |
B | D: 0.35 × 109 CFU OD | ||||
R | S: first feed | ||||
C | E: discharge | ||||
Serce, 2013 [27] | P | Preterm infants with GA ≤ 32 w and BW ≤ 1500 g, who survived to feed enterally | Saccharomyces boulardii | HM, FM | Distilled water |
M | D: 0.5 × 109 CFU/kg BD | ||||
R | S: non-specified | ||||
C | E: non-specified | ||||
Stratiki, 2007 [39] | P | Preterm infants with GA 27–32 w, formula-fed, without major congenital anomalies | Bifidobacterium lactis | FM | None |
B | D: 2 × 107 CFU/g of milk powder | ||||
R | S: start of enteral feeding | ||||
C | E: non-specified | ||||
Totsu, 2014 [46] | P | Infants with BW < 1500 g | Bifidobacterium bifidum | HM, FM | Dextrin |
DB |  | D: 2.5 × 109 CFU, divided in two doses | |||
CLR | Â | S: within 48Â h after birth | |||
C | Â | E: body weight 2000Â g | |||
Multic. |